Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study

Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study

Bibliographic Details
Main Authors:	Sawaki, Akira, Ohashi, Yasuo, Omuro, Yasushi, Satoh, Taroh, Hamamoto, Yasuo, Boku, Narikazu, Miyata, Yoshinori, Takiuchi, Hiroya, Yamaguchi, Kensei, Sasaki, Yasutsuna, Nishina, Tomohiro, Satoh, Atsushi, Baba, Eishi, Tamura, Takao, Abe, Takashi, Hatake, Kiyohiko, Ohtsu, Atsushi
Format:	Online
Language:	English
Published:	Springer Japan 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390686/

Similar Items

Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study
by: Yamaguchi, Kensei, et al.
Published: (2012)

Erratum to: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study
by: Yamaguchi, Kensei, et al.
Published: (2012)

Cost-effectiveness analysis of trastuzumab to treat HER2-positive advanced gastric cancer based on the randomised ToGA trial
by: Shiroiwa, T, et al.
Published: (2011)

HER2-positive gastric cancer
by: Boku, Narikazu
Published: (2013)

Phase II study of the effectiveness and safety of trastuzumab and paclitaxel for taxane‐ and trastuzumab‐naïve patients with HER2‐positive, previously treated, advanced, or recurrent gastric cancer (JFMC45‐1102)
by: Nishikawa, Kazuhiro, et al.
Published: (2016)

New developments in the treatment of metastatic gastric cancer: focus on trastuzumab
by: Rose, Jeffrey S, et al.
Published: (2011)

Coexistence of Gastric Adenocarcinoma and Choriocarcinoma: Complete Response to Trastuzumab and Chemotherapy
by: Gunduz, Seyda, et al.
Published: (2012)

Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer
by: Arienti, Chiara, et al.
Published: (2016)

A Retrospective Comparison of Trastuzumab Plus Cisplatin and Trastuzumab Plus Capecitabine in Elderly HER2-Positive Advanced Gastric Cancer Patients
by: Zhu, Bo, et al.
Published: (2015)

Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1)
by: Kurokawa, Y, et al.
Published: (2014)

Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectives
by: Davidson, Michael, et al.
Published: (2016)

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
by: Van Cutsem, Eric, et al.
Published: (2014)

Immune Effects of Trastuzumab
by: Nuti, Marianna, et al.
Published: (2011)

Target Points in Trastuzumab Resistance
by: Shojaei, Sahar, et al.
Published: (2012)

Psoriasis Induced by Trastuzumab (Herceptin®)
by: Kim, Dae Hun, et al.
Published: (2013)

Immune Effects of Trastuzumab
by: Marianna Nuti, Filippo Bellati, Valeria Visconti, Chiara Napoletano, Lavinia Domenici, Jlenia Caccetta, Ilaria Grazia Zizzari, Ilary Ruscito, Hassan Rahimi, Pierluigi Benedetti-Panici, Aurelia Rughetti
Published: (2011-01-01)

Trastuzumab emtansine in the treatment of HER2-positive metastatic breast cancer in Japanese patients
by: Sawaki, Masataka
Published: (2014)

Epstein-Barr virus gastric ulcer associated with ruxolitinib
by: Kusano, Yoshiharu, et al.
Published: (2016)

Shorter course of trastuzumab: Caveat emptor
by: Venniyoor, Ajit
Published: (2011)

Dilated cardiomyopathy following trastuzumab chemotherapy
by: Karmakar, Saurabh, et al.
Published: (2012)

Severe thrombocytopenia related to trastuzumab infusion
by: Mantzourani, Marina, et al.
Published: (2011)

Trastuzumab Cardiotoxicity in Patients with Breast Cancer
by: Freitas, Aguinaldo Figueiredo, et al.
Published: (2014)

Is there any advantage to combined trastuzumab and chemotherapy in perioperative setting her 2neu positive localized gastric adenocarcinoma?
by: Sbitti, Yassir, et al.
Published: (2011)

Durable Response of Human Epidermal Growth Factor Receptor-2-Positive Gastric Adenosquamous Carcinoma to Trastuzumab-Based Chemotherapy
by: Kadowaki, Shigenori, et al.
Published: (2014)

Evaluation of Trastuzumab Anti-Tumor Efficacy and its Correlation with HER-2 Status in Patient-Derived Gastric Adenocarcinoma Xenograft Models
by: Chen, Hao, et al.
Published: (2015)

Development of trastuzumab-resistant human gastric carcinoma cell lines and mechanisms of drug resistance
by: Zuo, Qiang, et al.
Published: (2015)

Panitumumab in Japanese Patients with Unresectable Colorectal Cancer: A Post-marketing Surveillance Study of 3085 Patients†
by: Boku, Narikazu, et al.
Published: (2014)

Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo
by: Barok, Mark, et al.
Published: (2011)

A Case of Trastuzumab-Associated Cardiomyopathy Presenting as an Acute Coronary Syndrome: Acute Trastuzumab Cardiotoxicity
by: Hidalgo, Sylvana, et al.
Published: (2013)

Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1)
by: Diessner, J, et al.
Published: (2014)

Population-based outcomes after brain radiotherapy in patients with brain metastases from breast cancer in the Pre-Trastuzumab and Trastuzumab eras
by: Karam, Irene, et al.
Published: (2013)

Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancer
by: Palmieri, Carlo, et al.
Published: (2015)

A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancer
by: Yoshino, Takayuki, et al.
Published: (2012)

Adjuvant trastuzumab in HER2-positive breast cancer.
by: Slamon, D., et al.
Published: (2011)

Trastuzumab in the management of early and advanced stage breast cancer
by: Bartsch, Rupert, et al.
Published: (2007)

Targeting HER2 in breast cancer: beyond trastuzumab
by: Winer, EP
Published: (2011)

Adjuvant trastuzumab: progress, controversies, and the steps ahead
by: Joy, A.A., et al.
Published: (2006)

HER2 therapy: Molecular mechanisms of trastuzumab resistance
by: Nahta, Rita, et al.
Published: (2006)

Trastuzumab-Induced Myocardiotoxicity Mimicking Acute Coronary Syndrome
by: Ribeiro, K.B., et al.
Published: (2012)

Trastuzumab: Updated Mechanisms of Action and Resistance in Breast Cancer
by: Vu, Thuy, et al.
Published: (2012)